Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Vivek Tripathi"'
Autor:
Chirantani Mukherjee, Vivek Tripathi, Eleni Maria Manolika, Anne Margriet Heijink, Giulia Ricci, Sarra Merzouk, H. Rudolf de Boer, Jeroen Demmers, Marcel A. T. M. van Vugt, Arnab Ray Chaudhuri
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Replication fork degradation can result in genome instability. Here authors reveal a role for Rif1 protein in protecting stalled replication forks from undergoing extensive, DNA2-dependent, degradation.
Externí odkaz:
https://doaj.org/article/cb070f743a7d4af79f8d12d89e2dfee4
Autor:
Vivek Tripathi, Himanshi Agarwal, Swati Priya, Harish Batra, Priyanka Modi, Monica Pandey, Dhurjhoti Saha, Sathees C. Raghavan, Sagar Sengupta
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Bloom helicase is recruited to double strand breaks in an ATM dependent manner. Here the authors show that Bloom helicase is recruited to double strand breaks in an ATM and MRN dependent manner with HR and NHEJ regulated by the helicase depending on
Externí odkaz:
https://doaj.org/article/c3555540331742b480d02601fab3415b
Autor:
Kapil Garg, Ruchi Srivastava, Pushpendra Kumar Verma, Anju Gautam, Vivek Tripathi, Satyendra Agarwal
Publikováno v:
Saudi Journal of Oral Sciences, Vol 4, Iss 1, Pp 33-40 (2017)
Introduction: For periodontal regeneration, various modalities are available; among these,use of growth factors is a developing area for clinicians and researchers, as they stimulate cells responsible for periodontal regeneration. Growth factor is a
Externí odkaz:
https://doaj.org/article/a65421a2c911441189fb709ff5cde62d
Autor:
Ruchi Srivastava, Pushpendra Kumar Verma, Vivek Tripathi, Pragya Tripathi, Ayush Razdan Singh
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 11, Pp ZJ05-ZJ06 (2016)
Externí odkaz:
https://doaj.org/article/e72378a3927947618a9f06076e54ed98
Autor:
Aparajita De, Vivek Tripathi
Publikováno v:
Genocides and Xenophobia in South Asia and Beyond ISBN: 9781003205470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4fc5797003f82cbbcf77b25f3bc03ee
https://doi.org/10.4324/9781003205470-2
https://doi.org/10.4324/9781003205470-2
Autor:
Vivek Tripathi, Suprita Raha
In today's era, it has become very crucial for businesses to stay on par with evolving technologies. The emergence of Digitalization has caused significant shifts in business operations. As a result, various industries have started reshaping their se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1896b59bd288d309d9efe8cd2f41cd66
Publikováno v:
Indian Journal Of Agricultural Research.
Background: Chickpea (Cicer arietinum L.) is one of the most important pulses. Helicoverpa armigera [Hubner] is the most devastating chickpea pest responsible for substantial yield loss. Chickpea crop is damaged by a large number of insect species, b
Autor:
Ke Cong, Jiri Bartek, Graeme C. Smith, Sharon B. Cantor, Jinhyuk Bhin, Marieke van de Ven, Miguel Andújar-Sánchez, Mariana Paes Dias, Vivek Tripathi, Stefano Annunziato, Eleni Maria Manolika, Cor Lieftink, Roderick L. Beijersbergen, Jos Jonkers, Ingrid van der Heijden, Jirina Bartkova, Arnab Ray Chaudhuri, Sanjiban Chakrabarty, Sven Rottenberg, Ewa Gogola, Panagiotis Galanos
Publikováno v:
Mol Cell
Molecular Cell, 81(22), 4692-4708.e9. Cell Press
Molecular Cell, 81(22), 4692-4708.e9. Cell Press
SUMMARYInhibitors of poly(ADP-ribose) (PAR) polymerase (PARPi) have entered the clinic for the treatment of homologous recombination (HR)-deficient cancers. Despite the success of this approach, preclinical and clinical research with PARPi has reveal
Autor:
Jirina Bartkova, Arnab Ray Chaudhuri, Marieke van de Ven, Panagiotis Galanos, Ke Cong, Sven Rottenberg, Jiri Bartek, Ingrid van der Heijden, Mariana Paes Dias, Jos Jonkers, Cor Lieftink, Sanjiban Chakrabarty, Roderick L. Beijersbergen, Miguel Andújar-Sánchez, Eleni-Maria Manolika, Ewa Gogola, Stefano Annunziato, Sharon B. Cantor, Vivek Tripathi
Publikováno v:
SSRN Electronic Journal.
Inhibitors of poly(ADP-ribose) (PAR) polymerase (PARPi) have entered the clinic for the treatment of homologous recombination (HR)-deficient cancers. Despite the success of this approach, preclinical and clinical research with PARPi has revealed mult
Publikováno v:
Journal of Experimental Biology and Agricultural Sciences. 6:684-689